Axicabtagene Ciloleucel Expanded Access Study
APPROVED_FOR_MARKETING
Status
Conditions
- Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Relapsed/Refractory Primary Mediastinal B Cell Lymphoma
- Relapsed/Refractory Transformed Follicular Lymphoma
- Relapsed/Refractory High-Grade B-Cell Lymphoma
Interventions
- BIOLOGICAL: Axicabtagene Ciloleucel
Sponsor
Kite, A Gilead Company